Cart
sales@molnova.com
Z-Gly-Gly-Arg-AMC TFA
CAS No. 66216-79-3
Z-Gly-Gly-Arg-AMC TFA( —— )
Catalog No. M22271 CAS No. 66216-79-3
Z-Gly-Gly-Arg-AMC is a thrombin-specific fluorogenic substrate for testing of thrombin generation in PRP and platelet-poor plasma (PPP).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 252 | In Stock |
|
| 5MG | 170 | In Stock |
|
| 10MG | 258 | In Stock |
|
| 25MG | 426 | In Stock |
|
| 50MG | 586 | In Stock |
|
| 100MG | 792 | In Stock |
|
| 200MG | 1051 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZ-Gly-Gly-Arg-AMC TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionZ-Gly-Gly-Arg-AMC is a thrombin-specific fluorogenic substrate for testing of thrombin generation in PRP and platelet-poor plasma (PPP).
-
DescriptionZ-Gly-Gly-Arg-AMC is a thrombin-specific fluorogenic substrate for testing of thrombin generation in PRP and platelet-poor plasma (PPP).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number66216-79-3
-
Formula Weight693.63
-
Molecular FormulaC30H34F3N7O9
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ivan D Tarandovskiy, Elena O Artemenko, Mikhail A Panteleev,et al.Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications.PLoS One. 2013;8(2):e55688.
molnova catalog
related products
-
Anemarrhenasaponin I
Anemarrhenasaponin I shows the remarkable inhibiting effect on platelet aggregation.
-
Vazegepant HCl
Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
-
Ianalumab
Ianalumab (VAY-736) is a decarboxylated humanized antibody against BAFF-R that inhibits the interaction between BAFF and BAFF-R, blocking BAFF-mediated apoptosis protection.
